Source: Annual Congress 2001 - Monitoring acute lung disease

Abstract

The aim of this study was to evaluate the pulmonary function test (PFT) of patients with postmenopausal osteoporosis and to compare their values with nonosteoporotic healthy subject.
Eighty-eight patients with postmenopausal osteoporosis and body -mass index (BMI) and age matched 54 healthy postmenopausal subjects were included in this study. Bone mineral density (BMD) of each group was assessed with Dual Energy X-ray Absorbsiometry (DXA). PFT was evaluated by a computerized Spiro meter (Sensor Medics, Vmax 22) Lateral thoracal X-ray was used to determine thoracal compression fractures. Patients having any compression fractures were excluded.
The mean lumber BMD of osteoporotic group was 0,81±]0,11.Control groups mean BMD was 0,90±]0,12.There was statistically significant difference between 2 groups.(p<0,001). Lumber T score of the patients[scquote] was –2,85±]0,83.Control group[scquote]s lumber T score was 0,006±] 1,05 (p<0,001). Osteoporotic group had significantly lower lumber T score values. Femur BMD values of patients group was 0,76±]0,11 and healthy controls had significantly higher femur BMD values 0,9±]0,009 (p<0,001). Femur neck T scores of patient group were –1,82±]0,89 and control group[scquote]s femur neck T score was –0,17±]0,71(p<0,001). Evaluating the PFT, there was no significant difference according FEVý, FVC, FEVý/FVC and FEF25-75 values between two groups, both of them normal ranges. Dispne scores of both groups didn[scquote]t show any significant difference either. In this study, we determined that postmenopausal osteoporotic patients had normal PFT values and didn[scquote]t have statistically significant difference compared to the controls.

Rating:

Share or cite this content

Citations should be made in the following way:
O. B. Cimen, B. Ulubas, S. Bagis, M. Calikoglu, G. Sahin (Mersin, Turkey). Evaluation of pulmonary function tests of patients with postmenopausal osteoporosis. Eur Respir J 2001; 16: Suppl. 31, 1656

Member's Comments

No comment yet.

Related content which might interest you: The effects of hormone therapy on pulmonary function tests in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 573s Year: 2004 The effects of hormone replacement therapy on pulmonary function in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 574s Year: 2004 Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Evaluation of the relationship between COPD and osteoporosis in Japanese patients Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Steroid osteoporosis prevention in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Relationship between pulmonary function and quality of life in women with osteoporosis or osteopenia Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016 FRAX program as a method of assessing the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 The differences of bone metabolism in males with chronic obstructive pulmonary disease and postmenopausal females Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Combined therapy of severe osteoporosis for patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018 Year: 2018 Peculiarities of sex hormonal status and incidence of osteoporosis in perimenopausal asthmatic women Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Pulmonary function in patients with acromegaly Source: Eur Respir J 2006; 28: Suppl. 50, 863s Year: 2006 Correlates of osteopenia and osteoporosis in COPD based on DXA-scan and X-spine Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease Year: 2010 Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 The assessment of thyroid functions in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 The absolute risk of osteoporotic fractures according to the program of FRAX patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012